Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Lung Drug Stops Deadly Child Cancers in Study
Bloomberg
Thursday, May 17, 2012 - 10:15am
tags:
Pfizer, Xalkori, anaplastic large-cell lymphoma
Abbott Helps Big Pharma Look Even Worse
TheStreet.com
Wednesday, May 16, 2012 - 1:39pm
tags:
Abbott Laboratories, Depakote
The Case For Keryx Biopharmaceuticals' Analyst Upgrade May Be Justified
Seeking Alpha
Wednesday, May 16, 2012 - 1:38pm
tags:
Keryx, upgrades, Aeterna Zentaris, Zerenex
Plavix Set to Lose Patent Protection
NY Times, NY
Wednesday, May 16, 2012 - 1:37pm
tags:
patents, Plavix, Bristol-Myers Squibb, Sanofi
Arena Pharmaceuticals Prices Public Offering of Common Stock
Yahoo
Wednesday, May 16, 2012 - 12:37pm
tags:
Arena Pharmaceuticals, stock offering
U.K. report says NICE drags its feet on drug approvals
Fierce Pharma
Wednesday, May 16, 2012 - 12:36pm
tags:
NICE, UK, drug approvals
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wednesday, May 16, 2012 - 12:27pm
tags:
ASCO, Genentech, T-DM1, breast cancer, tivozanib, Aveo, kidney cancer, Onyx, Bayer, regorafenib, colorectal cancer, Adcetris, Seattle Genetics, JNJ, prostate cancer, Zytiga, cabozantinib, Exelixis, Enzalutamide, Medivation, Ponatinib, chronic myeloid leukemia, Ariad Pharmaceuticals
Timing Is Right For Pfizer
Seeking Alpha
Wednesday, May 16, 2012 - 12:22pm
tags:
Pfizer, generics, Novartis, Sanofi, Eli Lilly, GSK, Human Genome Sciences
Glaxo Set to Acquire Cellzome
Yahoo/Zacks
Wednesday, May 16, 2012 - 12:21pm
tags:
Cellzome, GSK, M&A
GlaxoSmithKline closes on Theravance deal
Yahoo/AP
Wednesday, May 16, 2012 - 12:20pm
tags:
GSK, M&A, Theravance
Incyte's Potential Blockbuster Pipeline Asset Makes It An Attractive Takeover Target
Seeking Alpha
Wednesday, May 16, 2012 - 12:20pm
tags:
Incyte, Pfizer, M&A
India's Piramal to buy US healthcare company
Yahoo/AP
Wednesday, May 16, 2012 - 10:59am
tags:
India, M&A, Piramal Healthcare, Abbott Laboratories, Decision Resources Group
Amylin Goes A Little Wizard Of Oz On Shareholders
Seeking Alpha
Wednesday, May 16, 2012 - 10:58am
tags:
Amylin, AstraZeneca, Bristol-Myers Squibb, Pfizer, Sanofi, Novo Nordisk, M&A
Johnson & Johnson: Levaquin Success Great For Investors
Motley Fool
Wednesday, May 16, 2012 - 10:54am
tags:
JNJ, Levaquin, antibiotics
Pfizer, Johnson & Johnson, Ariad, and Medivation in Spotlight at Cancer Meeting
Minyanville
Wednesday, May 16, 2012 - 10:53am
tags:
ASCO, Pfizer, JNJ, Ariad Pharmaceuticals, Medivation
BMY Inks Deal with Chinese University
Yahoo/Zacks
Wednesday, May 16, 2012 - 10:49am
tags:
China, Bristol-Myers Squibb
Lpath Back In Play
Seeking Alpha
Tuesday, May 15, 2012 - 7:09pm
tags:
Lpath, Roche, Pfizer, Novartis, lipid signaling
Public Offerings Create Investing Opportunities In Biotech Sector
Seeking Alpha
Tuesday, May 15, 2012 - 1:17pm
tags:
stock offering, Amarin, Arena Pharmaceuticals, Celldex, Horizon Pharma, NeoStem, Repros Therapeutics, Oncothyreon, OncoSec
Anika Therapeutics: A Bio-Pharma Poised For Long Term Gains
Seeking Alpha
Tuesday, May 15, 2012 - 1:13pm
tags:
Anika
Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade
Seeking Alpha
Tuesday, May 15, 2012 - 12:12pm
tags:
ASCO, Allos, Ariad Pharmaceuticals, Arena Pharmaceuticals, Repligen, Sunesis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.